Refacto AF 500IU
País: Armênia
Língua: inglês
Origem: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
Folheto informativo - Bula
(PIL)
14-01-2014
Características técnicas
(SPC)
14-01-2014
Ingredientes ativos:
moroctocog alfa
Disponível em:
Wyeth Farma S.A.
DCI (Denominação Comum Internacional):
moroctocog alfa
Dosagem:
500IU
Forma farmacêutica:
powder for solution for injection
Tipo de prescrição:
Prescription
Folheto informativo - Bula
MRP Component Description:
Component
Packaging Plant
Item Code
Pharma Code
Barcode No.
Job No.
Pass No.
Date last modified
PIL REFACTO AF ES/UK/PT
180934
PATIENT LEAFLET
01
ALGETE
PAA024597
623
N/A
Black
Profile
Perigord House
Damastown Industrial Park
Dublin 15
Ireland
Telephone +353 (0)1 440 3222
info@perigordpremedia.com
ww.perigordpremedia.com
w
26 Sept 11
TEXT SIZE
THE BODY TEXT
ON THIS A/W IS AT:
8.0 PT
THE SMALLEST TEXT
ON THIS A/W IS AT:
4.7 PT
TINT VALUES
BLACK - 60%
BLACK - 50%
BLACK - 24%
BLACK - 16%
BLACK - 40%
BLACK - 29%
BLACK - 25%
MRP Component Description:
Component
Packaging Plant
Item Code
Pharma Code
Barcode No.
Job No.
Pass No.
Date last modified
PIL REFACTO AF ES/UK/PT
180934
PATIENT LEAFLET
01
ALGETE
PAA024597
623
N/A
Black
Profile
Perigord House
Damastown Industrial Park
Dublin 15
Ireland
Telephone +353 (0)1 440 3222
info@perigordpremedia.com
ww.perigordpremedia.com
w
6 mm
6 mm
To
place BarCode in the center
.
87,45 mm
90 mm
3,5 mm
Read Direction
FRONT
DIMENSION:
575 X 350 MM (FOLDED: 115 X 58,3 MM)
PAA000000
Bar code
(Laetus)
Non printable area
Bar code (Laetus) - High 5 mm
Code material - ALGETE
(Font: Helvetica, Size: 7)
Read Direction
PACKAGE LEAFLET: INFORMATION FOR THE USER
ReFacto AF 250 IU powder and solvent for solution for injection
ReFacto AF 500 IU powder and solvent for solution for injection
ReFacto AF 1000 IU powder and solvent for solution for injection
ReFacto AF 2000 IU powder and solvent for solution for injection
Moroctocog alfa (recombinant human coagulation factor VIII)
Read all of this leaflet carefully before you start taking this
medicine.
-
Keep this leaflet. You may need to read it again.
-
If you have further questions, please ask your doctor or your
pharmacist.
-
This medicine has been prescribed for you. Do not pass it on to
others. It may harm them, even if
their symptoms are the same as yours.
-
If you are concerned about any side effects or if you notice any side
effects not listed in this leaflet,
please tell your doctor or pharmacist.
In this leaflet:
1.
Leia o documento completo
